Valpovib 135mg/58mg Tablet CR
Marketer
Vibcare Pharma Pvt Ltd
Salt Composition
Sodium Valproate (135mg) + Valproic Acid (58mg)
Overview Valpovib 135mg/58mg Tablet CR
Epileptic seizures are managed by the dual-action Valpovib 135mg/58mg CR tablet, a formulation combining two anti-seizure medications. This medication regulates aberrant brain activity, promoting nerve relaxation and thus preventing seizure episodes. Administer Valpovib with food, following your physician's prescribed dosage regimen; this may be gradually increased until your condition stabilizes. While therapeutic effects may take weeks to manifest, consistent use is crucial. Discontinuation, except under medical guidance, risks increased seizure frequency or bipolar disorder exacerbation. Common adverse reactions include nausea and tremor; less frequent but possible effects involve vomiting, headache, liver impairment, and upper abdominal discomfort. Most side effects are transient; however, persistent or bothersome symptoms warrant medical attention, as management strategies exist. Prior to commencing treatment, disclose any pre-existing kidney or liver disease, meningitis, depression, or suicidal ideation. Inform your doctor of all concurrent medications, including contraceptives, as interactions may occur. Valpovib's use during pregnancy or breastfeeding is conditional upon necessity, necessitating potential dose adjustments. Avoid driving or cycling if drowsiness or dizziness arise. Regular blood tests monitor treatment efficacy. Alcohol should be avoided due to potential side effect intensification. Weight gain is a possibility; maintain a nutritious diet, limit high-calorie snacks, and engage in regular exercise. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal thoughts or actions immediately to your doctor.
Primary Ingredients of Valpovib 135mg/58mg Tablet CR
No information provided. Please provide the text you wish me to rephrase.
Uses of Valpovib 135mg/58mg Tablet CR
Seizure disorder
Major Benefits of Valpovib 135mg/58mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Valpovib 135mg/58mg Controlled-Release tablet whole; do not crush, chew, or divide it. Administer this medication with food.
Common Side effects of Valpovib 135mg/58mg Tablet CR:
- Nausea
- Tremors
How to use Valpovib 135mg/58mg Tablet CR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Valpovib 135mg/58mg Controlled-Release tablet whole; avoid chewing, crushing, or fracturing. Consume this medication with food.
How Valpovib 135mg/58mg Tablet CR works:
The extended-release tablet, Valpovib CR, contains 135mg of sodium valproate and 58mg of valproic acid, both anticonvulsant agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Valpovib 135mg/58mg CR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Valpovib 135mg/58mg tablets are contraindicated during pregnancy due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Valpovib 135mg/58mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking Valpovib 135mg/58mg Controlled-Release tablets can reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
The use of Valpovib 135mg/58mg CR tablets in patients with kidney disease is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, patients with pre-existing kidney conditions should consult their physician for personalized guidance.
LiverCAUTION
Patients with liver impairment should use Valpovib 135mg/58mg CR tablets cautiously; dosage modification may be necessary. Physician consultation is advised. Valpovib 135mg/58mg CR tablets are contraindicated in individuals with severe or active liver disease.
What if you forget to take Valpovib 135mg/58mg Tablet CR :
Should you forget a Valpovib 135mg/58mg CR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Valpovib 135mg/58mg Tablet CR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
3,018 People bought this recently